~~<i id='1911B856F6'><strike id='1911B856F6'><tt id='1911B856F6'><pre id='1911B856F6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：comprehensive 2025-09-27 13:09:48 - browse：963

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Palantir health business leans on meeting customers’ needs

hotspot

explore

focus

entertainment

hotspot

RichardHuckabee,seenwithhiswife,Angela,saysittooknineyearstobediagnosedwithParkinson’s.CourtesyRicha

WSS

The battle over the Brookhaven Landfill on Long Island

Living with Fabry disease, a condition that causes chronic pain

CDC concerned about possible undetected monkeypox spread in U.K.

Retired US general questions alleged Putin, Prigozhin meeting

Colonoscopy at 40? Study finds a possible benefit

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Wikipedia

leisure time

hotspot

How one medical school became remarkably diverse

The science behind Janet Jackson's pregnancy at 49

DIEP, the 'gold standard' of breast reconstruction, is under threat

Petition to FDA: Get the lead out of consumer hair dyes

How to save PrEP access — and even expand it

Cloning humans is technically possible. It's curious no one has tried

Walensky prepares to leave CDC — and Congress — behind

Leqembi, other new Alzheimer’s drugs require better biomarkers

As demand for Covid shots wanes, Moderna seeks its next success

#NeedHerScience: shining a light on gender disparities in medicine

hotspot

Oak trusses raised to roof of fire

It's time to get medical device identifiers over the finish line

Weight bias in eating disorder treatment complicated by new weight loss drugs

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Study: Pain burden is higher in Black NFL players than white ones

Do masks work? RCTs can't tell us

explore

focus

entertainment

hotspot